HomeCompareAAVMY vs PFE

AAVMY vs PFE: Dividend Comparison 2026

AAVMY yields 4.65% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AAVMY wins by $4096.90M in total portfolio value
10 years
AAVMY
AAVMY
● Live price
4.65%
Share price
$31.87
Annual div
$1.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4096.95M
Annual income
$3,934,405,054.61
Full AAVMY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — AAVMY vs PFE

📍 AAVMY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAAVMYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AAVMY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AAVMY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AAVMY
Annual income on $10K today (after 15% tax)
$395.25/yr
After 10yr DRIP, annual income (after tax)
$3,344,244,296.42/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, AAVMY beats the other by $3,344,221,976.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AAVMY + PFE for your $10,000?

AAVMY: 50%PFE: 50%
100% PFE50/50100% AAVMY
Portfolio after 10yr
$2048.50M
Annual income
$1,967,215,656.67/yr
Blended yield
96.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

AAVMY
Analyst Ratings
3
Buy
3
Hold
1
Sell
Consensus: Buy
Altman Z
-0.6
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AAVMY buys
0
PFE buys
0
No recent congressional trades found for AAVMY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAAVMYPFE
Forward yield4.65%6.13%
Annual dividend / share$1.48$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$4096.95M$49.6K
Annual income after 10y$3,934,405,054.61$26,258.71
Total dividends collected$4085.48M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: AAVMY vs PFE ($10,000, DRIP)

YearAAVMY PortfolioAAVMY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,630$929.99$9,153$693.39+$2.5KAAVMY
2$14,466$2,021.64$8,593$849.25+$5.9KAAVMY
3$20,178$4,700.15$8,336$1,066.78+$11.8KAAVMY
4$33,846$12,254.78$8,437$1,384.80+$25.4KAAVMY
5$74,636$38,420.91$9,013$1,875.40+$65.6KAAVMY
6$238,225$158,364.28$10,306$2,680.72+$227.9KAAVMY
7$1,199,706$944,805.85$12,820$4,101.38+$1.19MAAVMY
8$10,177,273$8,893,587.76$17,673$6,826.70+$10.16MAAVMY
9$151,909,367$141,019,684.70$27,543$12,591.86+$151.88MAAVMY
10$4,096,948,078$3,934,405,054.61$49,560$26,258.71+$4096.90MAAVMY

AAVMY vs PFE: Complete Analysis 2026

AAVMYStock

ABN AMRO Bank N.V. provides various banking products and services to retail, private, and business clients in the Netherlands and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company provides savings and deposits products; labelled residential mortgage products under the Florius brands; and consumer loans under the Alpha Credit Nederland, Credivance, Defam, Moneyou, and ABN AMRO brands. It also issues, promotes, manages, and processes credit cards; provides revolving credit card facilities and pension schemes, as well as consumer credit and mortgages; and life and non-life insurance products. In addition, it offers asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; private banking and wealth-management-related services; and derivatives and equity clearing services. ABN AMRO Bank N.V. was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands.

Full AAVMY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this AAVMY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AAVMY vs SCHDAAVMY vs JEPIAAVMY vs OAAVMY vs KOAAVMY vs MAINAAVMY vs JNJAAVMY vs MRKAAVMY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.